25

PowerPoint Presentation€¦ · Angina pectoris Mutations in LDL receptor, apolipoprotein B or PCSK9 . 200 E 150 100 Homozygous FH Heterozygous FH Female sex Smoking Hypertension

Download PDF Report

Upload
others
View
2
Download
0

Embed Size (px)

Citation preview

•• ≥ ≥

• ≥ ≥

•

•

•
•

•

•
•

•

•

Nordestgaard et al. Eur Heart J 2013; 34: 3478-3490

Further cardiovascular OUtcomes Research with PCSK9

Further cardiovascular OUtcomes Research with PCSK9

Documents

Further cardiovascular OUtcomes Research with PCSK9 ...clinicaltrialresults.org/Slides/ACC2017/Fourier_Sabatine.pdf · Further cardiovascular OUtcomes Research with PCSK9 Inhibition

Further cardiovascular OUtcomes Research with PCSK9 ...clinicaltrialresults.org/Slides/ACC2017/Fourier_Sabatine.pdf · Further cardiovascular OUtcomes Research with PCSK9 Inhibition

Documents

apolipoprotein abnormalities in coronary artery disease

apolipoprotein abnormalities in coronary artery disease

Documents

Metabolisme Kolesterol, Lipoprotein Dan Apolipoprotein

Metabolisme Kolesterol, Lipoprotein Dan Apolipoprotein

Documents

PCSK9 Inhibitors

PCSK9 Inhibitors

Documents

PCSK9 Inhibitors, The Most Significant Advance in Lipid ...Wilson PCSK9 Inhibitors 25 of the first PCSK9 inhibitors in 2015, Repatha (evolocumab) and Praluent (alirocumab) both indicated

PCSK9 Inhibitors, The Most Significant Advance in Lipid ...Wilson PCSK9 Inhibitors 25 of the first PCSK9 inhibitors in 2015, Repatha (evolocumab) and Praluent (alirocumab) both indicated

Documents

RegulationofEpithelialSodiumChannelTraffickingby ... · RegulationofEpithelialSodiumChannelTraffickingby ProproteinConvertaseSubtilisin/KexinType9(PCSK9)* ... convertasefamily,cleavestheextracellulardomainof

RegulationofEpithelialSodiumChannelTraffickingby ... · RegulationofEpithelialSodiumChannelTraffickingby ProproteinConvertaseSubtilisin/KexinType9(PCSK9)* ... convertasefamily,cleavestheextracellulardomainof

Documents

Treatment of severe Familial Hypercholesterolemia PCSK9 ... · Treatment of severe Familial Hypercholesterolemia PCSK9 inhibitors ... Hospital Carl Gustav Carus, ... severe Familial

Treatment of severe Familial Hypercholesterolemia PCSK9 ... · Treatment of severe Familial Hypercholesterolemia PCSK9 inhibitors ... Hospital Carl Gustav Carus, ... severe Familial

Documents

PCSK9 targeting for the treatment of dyslipidemia

PCSK9 targeting for the treatment of dyslipidemia

Documents

Serum apolipoprotein B/apolipoprotein A1 ratio in relation

Serum apolipoprotein B/apolipoprotein A1 ratio in relation

Documents

PCSK9 Loss-of-function Mutations

PCSK9 Loss-of-function Mutations

Documents

PCSK9 INHIBITORS, ARNIS, FUNNY CHANNEL INHIBITORS…extranet.provhealth.org/extranet/cardio/Presentations/Are these... · pcsk9 inhibitors, arnis, funny channel inhibitors: are you

PCSK9 INHIBITORS, ARNIS, FUNNY CHANNEL INHIBITORS…extranet.provhealth.org/extranet/cardio/Presentations/Are these... · pcsk9 inhibitors, arnis, funny channel inhibitors: are you

Documents

IDENTIFICATION OF INHIBITORS FOR PCSK9

IDENTIFICATION OF INHIBITORS FOR PCSK9

Science

Facilitating Patient Access To PCSK9 Inhibitors

Facilitating Patient Access To PCSK9 Inhibitors

Documents

The PCSK9 decade - The Journal of Lipid Research PCSK9 decade Lambert, at al. 1 The PCSK9 decade Gilles Lambert,1,3 Barbara Sjouke,2 Benjamin Choque,3 John J. P. Kastelein,2 G. Kees

The PCSK9 decade - The Journal of Lipid Research PCSK9 decade Lambert, at al. 1 The PCSK9 decade Gilles Lambert,1,3 Barbara Sjouke,2 Benjamin Choque,3 John J. P. Kastelein,2 G. Kees

Documents

Apolipoprotein E Deficiency Increases Remnant Lipoproteins ... › ws › files › 139329962 › befo_1_s2.0_S2… · experimental atherosclerosis is the apolipoprotein E (APOE)–deﬁcient

Apolipoprotein E Deficiency Increases Remnant Lipoproteins ... › ws › files › 139329962 › befo_1_s2.0_S2… · experimental atherosclerosis is the apolipoprotein E (APOE)–deﬁcient

Documents

Decreased PCSK9 expression in human hepatocellular carcinoma · 2017. 8. 24. · Keywords: Hepatocellular carcinoma, PCSK9, Tumor metabolism * Correspondence: mamatha.bhat@mcgill.ca

Decreased PCSK9 expression in human hepatocellular carcinoma · 2017. 8. 24. · Keywords: Hepatocellular carcinoma, PCSK9, Tumor metabolism * Correspondence: [email protected]

Documents

Apolipoprotein structural organization in high density ...homepages.uc.edu/~davidswm/COP-Davidson.pdf · Apolipoprotein structural organization in high density lipoproteins: belts,

Apolipoprotein structural organization in high density ...homepages.uc.edu/~davidswm/COP-Davidson.pdf · Apolipoprotein structural organization in high density lipoproteins: belts,

Documents

PCSK9 mutations in hypercholesterolemia - bioRxiv...2019/08/22 · PCSK9 mutations in hypercholesterolemia 1 A transient amphipathic helix in PCSK9’s prodomain facilitates low-density

PCSK9 mutations in hypercholesterolemia - bioRxiv...2019/08/22 · PCSK9 mutations in hypercholesterolemia 1 A transient amphipathic helix in PCSK9’s prodomain facilitates low-density

Documents

PCSK9...Bryan Heart Fall Conference 2015 PCSK9 Inhibitors Current Status Title Microsoft PowerPoint - PCSK9.pptx Author tlw011 Created Date 9/2/2015 3:31:45 PM

PCSK9...Bryan Heart Fall Conference 2015 PCSK9 Inhibitors Current Status Title Microsoft PowerPoint - PCSK9.pptx Author tlw011 Created Date 9/2/2015 3:31:45 PM

Documents

An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top ...An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top ... ... 2012, 8

An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top ...An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top ... ... 2012, 8

Documents

Clusterin/Apolipoprotein J immunoreactivity is associated

Clusterin/Apolipoprotein J immunoreactivity is associated

Documents

Antihyperlipidemics – Apolipoprotein B Synthesis Inhibitors · Antihyperlipidemics – Apolipoprotein B Synthesis Inhibitors: lomitapide mesylate Medical policy no. 39.48.00 Effective

Antihyperlipidemics – Apolipoprotein B Synthesis Inhibitors · Antihyperlipidemics – Apolipoprotein B Synthesis Inhibitors: lomitapide mesylate Medical policy no. 39.48.00 Effective

Documents

Update on PCSK9 Inhibitors

Update on PCSK9 Inhibitors

Documents

Plasma Lipoproteins: Apolipoprotein structure and Function

Plasma Lipoproteins: Apolipoprotein structure and Function

Documents

$PCSK9 Inhibition : From Genetics to Patients · PCSK9 mutations and impact on LDL-C\爀屲 PCSK9 mutations represent the major source of variability in PCSK9 expression. Two type\൳$

PCSK9 Inhibition : From Genetics to Patients · PCSK9 mutations and impact on LDL-C\爀屲 PCSK9 mutations represent the major source of variability in PCSK9 expression. Two type\൳

Documents

PCSK9 Inhibitors - Praluent (Alirocumab) and Repatha ...€¦ · PCSK9 Inhibitors Praluent (Alirocumab) and Repatha (Evolocumab) For the Treatment of Familial Hypercholesterolemia

PCSK9 Inhibitors - Praluent (Alirocumab) and Repatha ...€¦ · PCSK9 Inhibitors Praluent (Alirocumab) and Repatha (Evolocumab) For the Treatment of Familial Hypercholesterolemia

Documents

2012/11 - IR - PCSK9

2012/11 - IR - PCSK9

Documents

I (OR MY FAMILY MEMBER) AM READY TO GET ......as cholesterol absorption inhibitors (eg, ezetimibe) and PCSK9 inhibitors. Switching to another medication helped this FH patient to maintain

I (OR MY FAMILY MEMBER) AM READY TO GET ......as cholesterol absorption inhibitors (eg, ezetimibe) and PCSK9 inhibitors. Switching to another medication helped this FH patient to maintain

Documents

Anti-PCSK9 Antibody Effectively Lowers Cholesterol in ...news.medlive.cn/uploadfile/20140331/13962331196199.pdf · Accepted Manuscript Anti-PCSK9 Antibody Effectively Lowers Cholesterol

Anti-PCSK9 Antibody Effectively Lowers Cholesterol in ...news.medlive.cn/uploadfile/20140331/13962331196199.pdf · Accepted Manuscript Anti-PCSK9 Antibody Effectively Lowers Cholesterol

Documents